Spero Therapeutics
SPRO
SPRO
50 hedge funds and large institutions have $16.1M invested in Spero Therapeutics in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $16.5M → $16.1M (-$391K)
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$900K | |
| 2 | +$160K | |
| 3 | +$135K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$94.2K |
| 5 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$92.1K |
Top Sellers
| 1 | -$628K | |
| 2 | -$447K | |
| 3 | -$101K | |
| 4 |
Man Group
London,
United Kingdom
|
-$51.6K |
| 5 |
Millennium Management
New York
|
-$43.1K |